Recently, molecular imaging has become a conditio sine qua non for cell-based regenerative medicine. Developments in molecular imaging techniques, such as reporter gene technology, have increasingly enabled the noninvasive assessment of the fate and biology of cells after cardiovascular applications. In this context, bioluminescence imaging is the most commonly used imaging modality in small animal models of preclinical studies. Here, we present a detailed protocol of a reporter gene imaging approach for monitoring the viability and biology of Mesenchymal Stem Cells transplanted in a mouse model of myocardial ischemia reperfusion injury.
CITATION STYLE
Franchi, F., & Rodriguez-Porcel, M. (2017). Noninvasive assessment of cell fate and biology in transplanted mesenchymal stem cells. In Methods in Molecular Biology (Vol. 1553, pp. 227–239). Humana Press Inc. https://doi.org/10.1007/978-1-4939-6756-8_18
Mendeley helps you to discover research relevant for your work.